• The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month

• The Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, an important criterion for CMS penalties.

CARDIO inCode-Score Genetic Risk Influences Cholesterol Risk and Prediction of Coronary Heart Disease

Partnership launches AI solution to enhance predictive heart valve visualization and personalize valve treatment planning decisions enabling the future of TAVR for structural heart patients

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's Number One Killer

Mass General Brigham expands the reach of its Medicare-approved Benson-Henry Institute Intensive Cardiac Rehabilitation program through virtual and center-based partnerships

Doctor-Formulated Saffron Supplement Backed by Science for Natural Blood Pressure and Cardiovascular Support in 2025

Australian Company Announces Landmark Paper Showing Cyclodextrin Therapy Reverses Heart Disease, Hailed as ‘Greatest Development Since Statins’

The new 4-in-1 cardiovascular screening package helps adults over 40 detect stroke and heart attack risks early through non-invasive, physician-reviewed tests aligned with updated AHA prevention guidelines.

Clinically-informed routines backed by garlic, hawthorn berry, and hibiscus highlight Heart Freedom's botanical approach to sustained blood pressure support, circulation enhancement, and heart health integration in 2025.

New Cardiovascular Formula Lipidene Gains Attention for Natural Cholesterol and Artery Health Support, Backed by Botanical Science and Clinical Ingredient Data

Cardio Shield, developed by Apollo Research, emerges as the leading cardiovascular supplement of 2025 with a clinically inspired, natural formula designed to support blood pressure, circulation, and heart function - backed by real user results, scientific validation, and a 180-day risk-free guarantee.

Clinically dosed with standardized bergamot and hydroxytyrosol, the new Lipidene supplement offers a natural approach to lipid health and heart support aligned with 2025 wellness trends.

Explore the natural formula behind Blood Pressure 911-PhytAge Laboratories' most trusted supplement for promoting heart health, improving circulation, and supporting healthy blood pressure levels in 2025.

• Despite differences in characteristics and treatment, the pFCG test distinguished risk of the primary ischemic endpoint to a similar extent in the 2 groups.

• No significant association was observed between pFCG and risk of bleeding.

Date: March 31, 2025, 10:36 A.M. 

Location: Moderated Poster Theater 7

PROGNOSTIC IMPLICATIONS OF PLATELET FCɣRIIA DURING THE FIRST YEAR AFTER MYOCARDIAL INFARCTION

National insurance distribution company expresses the importance of fixed cash benefits from hospital indemnity plans to help seniors manage out-of-pocket costs and focus on recovery

The 12,000 sq ft multispecialty clinic provides family medicine, specialty care like internal medicine, urology and interventional cardiology, and diagnostic services including lab and imaging, all in one place.

Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention

Breaking down the silos between departments opens up an exciting new level of efficiency, cost savings, communication, and faster, more informed decision-making.